SOURCE: Xtalks

Xtalks Webinars

January 18, 2016 15:00 ET

Top News Stories You Might have Missed From Xtalks

Xtalks Provides Current Articles Daily in the Life Science Industry

TORONTO, ON--(Marketwired - January 18, 2016) - Check out all news stories here: http://xtalks.com/News.ashx. Subscribe to our weekly newsletter: http://register.xtalks.com/newsblogs.

Politics Of Cancer Prevents Development Of A Cure, Says VP Joe Biden -- http://ow.ly/XdWQo
(Jan 18) US Vice President Joe Biden announced his cancer moonshot program -- an initiative backed by an infusion of funding into cancer research -- following the death of his son to brain cancer last year.

Bayer Opens Manufacturing Facility In China For OTC Drugs -- http://ow.ly/XdXtY
(Jan 18) Last week, German pharmaceutical giant, Bayer, opened a manufacturing plant in China, where both traditional Chinese medicines and Western over-the-counter (OTC) drugs, will be made.

Zika Virus Diagnosed In US Has Experts Calling For Vaccine -- http://ow.ly/XdY2b
(Jan 15) An individual in Texas has been diagnosed with a Zika virus infection -- a pathogen that has been linked to birth defects in newborns.

Dr. Robert Califf Approved By Senate Panel As FDA Commissioner -- http://ow.ly/XdY8c
(Jan 15) Back in September of 2015, President Barack Obama named Dr. Robert Califf -- a respected cardiologist and researcher -- as his nomination for the Food and Drug Administration (FDA) Commissioner.

Multi-Drug Microcapsules Could Improve Chemotherapy Drug Delivery -- http://ow.ly/XdYdu
(Jan 14) Researchers from Ohio State University in the US and the University of Science and Technology of China have developed tiny capsules capable of keeping two cancer drug ingredients separated until they are triggered by a signal to mix at the site of a tumor.

Immunotherapy Potentially Effective Against Two Deadly Ebola Strains -- http://ow.ly/XdYj1
(Jan 14) Antibodies developed by researchers at Albert Einstein College of Medicine, in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), may be effective against the two most lethal strains of the Ebola virus.

Illumina To Develop Blood Test For Early Detection Of Cancer -- http://ow.ly/XdYnS
(Jan 13) San Diego-based sequencing company Illumina has announced they will be developing blood tests for early-detection of a wide range of cancers, before patients develop any symptoms.

Arthritis Drug Could Prove Useful In Treating BRCA1-Positive Ovarian Cancer -- http://ow.ly/XdYAP
(Jan 13) According to a study led by researchers at the University of Plymouth in the UK, a drug used to treat rheumatoid arthritis -- called auranofin -- could improve patient outcomes for women with ovarian cancer with a BRCA1 mutation.

Shire Finalizes Deal To Acquire Baxalta For $32 Billion -- http://ow.ly/XdYI1
(Jan 12) After six months of negotiations, Shire has finally announced they've reached an agreement to acquire Baxalta for $32 billion.

Johnson & Johnson Announces New Collaborations And Seeks Hepatitis B Cure -- http://ow.ly/XdYUd
(Jan 12) In anticipation of the 33rd annual J.P. Morgan Healthcare Conference, Johnson & Johnson will be announcing 21 new collaborations covering experimental disease treatments, medical devices and consumer health products

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.

Contact Information